Related Experiment Video
Updated: Apr 7, 2026
08:56
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
3.6K
[Polyneuropathy in elderly patients]
L T Akhmedzhanova1, A N Barinov1
1Sechenov First Moscow State Medical University, Moscow.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|July 15, 2015
Summary
This study examines peripheral nervous system disorders in older adults, focusing on pathogenesis and treatment. It proposes integrated therapies including antiepileptic drugs, B vitamins, and alpha-lipoic acid for polyneuropathy.
Area of Science:
- Neurology
- Geriatrics
- Pathophysiology
Context:
- Peripheral nervous system (PNS) lesions are common in elderly patients.
- Understanding the specific characteristics of pathogenesis and clinical presentation in this demographic is crucial.
- Existing treatment strategies for polyneuropathy in the elderly require analysis.
Purpose:
- To analyze the pathogenesis and clinical characteristics of peripheral nervous system lesions in elderly individuals.
- To evaluate current pathogenetic and symptomatic treatment approaches for polyneuropathy in this population.
- To propose comprehensive treatment strategies for elderly patients with polyneuropathy.
Summary:
- The article details the pathogenesis and clinical manifestations of peripheral nervous system damage in the elderly.
- It reviews current treatment modalities for polyneuropathy, considering both pathogenetic and symptomatic aspects.
- A complex therapeutic approach is recommended, incorporating antiepileptic drugs, B vitamins, and alpha-lipoic acid.
Impact:
- Provides insights into the specific challenges of treating peripheral neuropathies in older adults.
- Offers a framework for integrated treatment strategies to improve patient outcomes.
- Highlights the potential benefits of combining pharmacological agents like antiepileptic drugs, B vitamins, and alpha-lipoic acid in managing elderly polyneuropathy.
More Related Videos
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
325
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
325
01:15Drug Dosing: Geriatric Patients
358
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
358
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
321
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
321
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
813
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
813
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
333
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
333
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
346
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
346